Carregant...

Gender‐related differential effect of tachykinin NK(2) receptor‐mediated visceral hyperalgesia in guinea pig colon

BACKGROUND AND PURPOSE: The tachykinin NK(2) receptor antagonist ibodutant is under Phase III clinical investigation to treat female patients with irritable bowel syndrome. The aim of this study was to investigate the NK(2) receptor‐related gender specificity in a model of colitis. EXPERIMENTAL APPR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Pharmacol
Autors principals: Bellucci, F, Buéno, L, Bugianesi, R, Crea, A, D'Aranno, V, Meini, S, Santicioli, P, Tramontana, M, Maggi, CA
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940818/
https://ncbi.nlm.nih.gov/pubmed/26758701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13427
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!